PISCATAWAY, N.J, April 1, 2020 /PRNewswire/ -- GenScript, a world leading biotechnology company, today announced the commercial launch of its neoantigen peptide synthesis service for biotech and ...
Many promising peptides fail because they degrade too easily. This limits their usefulness in drug design and creates ...
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of three service offerings ...
A team of researchers from the University of Utah and Sethera Therapeutics has uncovered a powerful new way to build more stable and drug-like peptides, opening the door to medicines that could target ...
Eli Lilly and Merck & Co. have identified PeptiDream’s peptides as a way to deliver therapeutic payloads to targets, leading them both to lay down more than $1 billion in milestones to work with the ...
Reported positive topline results from the Phase 2 Avail™ trial of once-weekly canvuparatide in hypoparathyroidism (HP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback